Facial nerve dysfunction. Injury of facial nerve
Conditions
Interventions
Intervention 1: Eight milligrams of intravenous dexamethasone injection in the patients of drug (intervention) group 4 hours before the parotidectomy. Intervention 2: Two milliliters of normal saline
Treatment - Drugs
Eight milligrams of intravenous dexamethasone injection in the patients of drug (intervention) group 4 hours before the parotidectomy
Two milliliters of normal saline intravenous injection in the patients of placebo (control) group 4 hours before the parotidectomy
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with benign parotid tumor and normal facial nerve function Exclusion criteria: patients with history of diabetes mellitus; history of autoimmune diseases; sensitivity to corticosteroids and other contraindications of these medicines; history of corticosteroid use; tumor spread to deep lobe; history of previous surgery of the parotid; history of face and neck radiotherapy; history of malignant disease in parotid gland and face; and preoperative facial nerve dysfunction in each branch
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial nerve dysfunction. Timepoint: First day, one week and one month after the surgery. Method of measurement: Physical exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Involved branches of facial nerve. Timepoint: First day, one week and one month after the surgery. Method of measurement: Physical exam.;Size of tumor. Timepoint: After surgery. Method of measurement: Lab.;Histologic type of tumor. Timepoint: After surgery. Method of measurement: Lab.;Position of tumor. Timepoint: During surgery. Method of measurement: Visual. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Kasra Tavassoli
Tabriz University of Medical Sciences
Outcome results
None listed